Genetic programme of cardiogenesis: implications for therapeutic application.

Abstract

It has become accepted that new cardiomyocytes can be derived from stem cells. Although the potential for therapeutic application is evident, the reported efficiency of differentiation varies greatly from 0.02 to 54%. To obtain clinically relevant numbers of newly differentiated cardiac cells, stem cell differentiation should be as efficient as possible. A… (More)

Topics

  • Presentations referencing similar topics